In States, Some Resistance to New Opioid Limits

 

Connecting state and local government leaders

As the prescription drug, heroin and fentanyl epidemic escalates, states are enacting laws to curtail painkiller prescribing. Doctors fear unintended consequences.

This article was originally published at Stateline, an initiative of The Pew Charitable Trusts, as part of the Stateline Legislative Review 2016 and was written by Christine Vestal.

For governors and lawmakers in nearly every state, the soaring overdose death toll from prescription painkillers, heroin and fentanyl has become an urgent priority.

Lawmakers in dozens of states took decisive action this year to stanch the flow of prescription pain drugs and help those addicted to them. Roughly 2.5 million Americans are addicted to opioids, and more than 28,000 people died of overdoses of painkillers or heroin in 2014, the highest toll ever.

To keep even more people from becoming addicted to medicines such as Percocet, OxyContin and Vicodin, lawmakers in five states set limits on the number of pills a physician can prescribe to a patient for the first time. Twenty-nine states beefed up monitoring of filled prescriptions to prevent addicts from “doctor shopping” for more pills.

Sixteen states expanded the use of naloxone, an overdose antidote drug few lawmakers had heard of just a year ago. And at least nine states adopted requirements that Medicaid and other insurers pay for all medically recommended addiction services, just as they would for other diseases, according to the National Conference of State Legislatures (NCSL).

Among lawmakers, governors and the medical community, there is broad support for measures aimed at rescuing people from fatal overdoses, providing more addiction treatment options and keeping highly addictive opioid pain medicines out of the hands of those who might abuse them. More doctors and patients are beginning to eschew opioids for alternatives such as anti-inflammatory medications, exercise, physical therapy, acupuncture and psychotherapy.

But the new laws are not without controversy. In several Northeast states, doctors are balking at new limits on the number of pills hospital emergency departments, physicians, dentists or nurses can prescribe for acute pain. Prominent medical groups, including the American Medical Association, argue that doctors and patients, rather than lawmakers, should be able to balance the need for pain relief against the risk of addiction in individual cases.

Prescribing Limits

Dr. Yngvild Olsen, past president of the Maryland Society of Addiction Medicine, said the prescription limits, typically a seven-day supply of pills for a minor procedure or injury such as a tooth extraction or sprained ankle, could cause some doctors to simply stop prescribing opioids because many of them bristle at being told how to practice.

“Arbitrary pill limits or dosage limits are not the way to go,” said Dr. Patrice Harris, chairwoman of AMA’s committee on opioid abuse. “They are one-size-fits-all, blunt approaches.”

Dr. Andrew Kolodny, director of Physicians for Responsible Opioid Prescribing, said patients would be better served if states urged doctors to talk to them about the risk of addiction and required a signed informed consent before prescribing. States also could require doctors to write a detailed treatment plan before prescribing opioids, and insist that prescribers seek prior authorization from a pain expert before prescribing high doses of opioids, he said.

In March, the U.S. Centers for Disease Control and Prevention released recommendations for primary care physicians and others who prescribe opioid painkillers, the first time a federal agency has issued prescribing directives. The agency called on prescribers to voluntarily limit their first prescriptions for acute pain to a three-day supply or less, rather than a 30-day supply, which is common practice in most hospitals and physicians’ offices. The final guidelines noted that “more than seven days will rarely be needed.”

After the CDC released its preliminary recommendations late last year, Massachusetts Gov. Charlie Baker proposed a mandatory three-day limit on first-time opioid prescriptions. State legislators opposed three days but agreed to seven, and Baker, a Republican, signed the compromise bill in March.

Seven-day limits also were adopted in Connecticut, New York, Maine and Rhode Island this year. Vermont left the precise number of days or pills for acute pain up to the state Health Department, which will consult with the state Medical Society before issuing a final rule.

In part, states were spurred to action by a National Governors Association committee formed to develop a unified state response to the opioid crisis.

At a February meeting of the group, Vermont Gov. Peter Shumlin, a Democrat, called on fellow governors to stop doctors from handing out painkillers like candy or prescribing them “just in case” a patient needs them.

Prescription Drug Monitoring

In contrast to prescribing limits, there is little resistance to tougher prescription monitoring laws. States have been tracking prescriptions for opioids and other federally regulated substances since the 1930s, primarily as a tool for law enforcement. Today, every state except Missouri has some type of tracking system, but the rules governing who has access to the information, how quickly pharmacies must enter dispensing data, and which medications are included vary widely. 

By tapping into a database of prescriptions, doctors can check patients’ opioid medication history, as well as their use of other potentially harmful drugs, such as sedatives and muscle relaxants, to better assess the risk of addiction or overdose death. A new study by researchers at Vanderbilt University in Tennessee found that state tracking systems have helped lower overdose deaths over the last 20 years.

This year at least 29 states updated their prescription monitoring statutes to improve their effectiveness.

Updates include requirements that pharmacists track more medications and upload the data as prescriptions are filled rather than weekly or monthly, new provisions allowing prescribers to delegate a member of their team to access the confidential information, and requirements that physicians review nearly all patients’ prescription drug histories before prescribing opioids or other dangerous or addictive medications.

Emergency Overdose Treatment

Most fatal opioid overdose victims die from a lack of oxygen because their lungs shut down one to three hours after taking a drug. That leaves a substantial amount of time for a friend, family member or bystander to administer naloxone (sold as Narcan), which is highly effective at reversing the effects of opioid intoxication.

Naloxone was federally approved in 1971, but until the late 1990s it was only used in hospital emergency departments and operating rooms. Even emergency medical personnel and other first responders did not use the rescue drug initially.

The opioid epidemic, which first took hold in New England and Appalachia around 2006, changed that. As of last week, all but three states — Kansas, Montana and Wyoming — had laws ensuring first responders and others could get access to the life-saving drug.

In addition, at least 32 states and the District of Columbia have so-called good Samaritan laws that provide varying levels of legal immunity to bystanders who call for help when someone has overdosed on drugs.

This year, Alaska, Arizona, Hawaii, Iowa, Missouri and South Dakota enacted naloxone laws. Ohio enacted a “good Samaritan” law and Rhode Island renewed one that had expired.

More Treatment

Since January 2015, several states, including Ohio, Illinois, Indiana, Massachusetts, New Jersey, New Mexico, New York, Rhode Island and West Virginia, have adopted new laws aimed at expanding addiction treatment services for the growing number of people seeking them, according to NCSL.

New York’s new addiction treatment law, for example, requires insurers to give people seeking treatment immediate access to care and to cover at least 14 days of continuous treatment before requiring authorization from providers. It also requires health care providers to use objective, state-approved criteria to determine what level of care a patient needs.

To protect patients from potential overdose, New York’s new law also allows families to seek 72 hours of emergency treatment, up from 48 hours.

Some states, including California, Indiana and Missouri, adopted new Medicaid rules to ensure enrollees with drug addictions have access to high quality treatment options, including medications, residential care and outpatient counseling and therapy, according to the National Association of Medicaid Directors.

An influx of federal money could prompt more states to adopt addiction treatment measures. President Obama’s proposed 2017 budget includes $1.1 billion to help states make medication-assisted treatment more available to opioid addicts.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.